Viewing Study NCT00499135


Ignite Creation Date: 2025-12-24 @ 10:17 PM
Ignite Modification Date: 2026-05-29 @ 9:14 PM
Study NCT ID: NCT00499135
Status: COMPLETED
Last Update Posted: 2017-10-10
First Post: 2007-07-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Solid Neoplasm View
None Clear Cell Renal Cell Carcinoma View
None Recurrent Renal Cell Carcinoma View
None Stage III Renal Cell Cancer View
None Stage IV Renal Cell Cancer View
Keywords: